Lifeward (LFWD) FCF Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,748.00 |
| Dec 31, 2025 | 13,213.00 |
| Sep 30, 2025 | 29,307.00 |
| Jun 30, 2025 | 12,359.00 |
| Mar 31, 2025 | 46,301.00 |
| Dec 31, 2024 | 25,256.00 |
| Sep 30, 2024 | 19,215.00 |
| Jun 30, 2024 | 33,849.00 |
| Mar 31, 2024 | 12,377.00 |
| Dec 31, 2023 | 9,901.00 |
| Sep 30, 2023 | 2,334.00 |
| Jun 30, 2023 | -3,387.00 |
| Mar 31, 2023 | -10,714.00 |
| Dec 31, 2022 | 17,831.00 |
| Sep 30, 2022 | -18,273.00 |
| Jun 30, 2022 | 2,340.00 |
| Mar 31, 2022 | -41,028.00 |
| Dec 31, 2021 | 20,614.00 |
| Sep 30, 2021 | 34,774.00 |
| Jun 30, 2021 | 61,677.00 |
| Mar 31, 2021 | 10,105.00 |
| Dec 31, 2020 | 34,415.00 |
| Sep 30, 2020 | -86,354.00 |
| Jun 30, 2020 | -115,517.00 |
| Mar 31, 2020 | 45,645.00 |
| Dec 31, 2019 | -11,990.00 |
| Sep 30, 2019 | -64,374.00 |
| Jun 30, 2019 | -118,403.00 |
| Dec 31, 2018 | 54,672.00 |
| Sep 30, 2018 | -73,535.00 |